Table 1 Thermodynamic parameters for halogenated benzotriazoles in solution (in silico LogP), for their binding to the catalytic subunit of human protein kinase CK2 and viability of selected human cell lines, IC50 values, in response to tested compounds.
From: 5,6-diiodo-1H-benzotriazole: new TBBt analogue that minutely affects mitochondrial activity
Parameter | Ligand | ||||
|---|---|---|---|---|---|
HBBH | TBBt | HIIH | BIIB | cisPt | |
LogPa18 | 2.88 | 4.56 | 3.93 | 5.59 | |
DSFa | |||||
ΔTm [K] | 7.4 ± 0.118 | 9.0 ± 0.118 | 8.3 ± 0.120 | 10.8 ± 0.120 | |
MST | |||||
Kd1 (nM) | 29 ± 13 | 16 ± 18 | 15 ± 7 | 3 ± 6 | |
Kd2b (nM) | 327 ± 95 | 130 ± 88 | 374 ± 83 | 43 ± 22 | |
ITC | |||||
Kd1 (nM) | 34 ± 4 | 16c | 22 ± 4 | 1.3 ± 1.4 | |
ΔH1 (kJ/mol) | − 58 ± 1 | − 22 ± 4 | − 55 ± 1 | − 14.0 ± 0.5 | |
ΔS1 (J/mol/K) | − 52 ± 4 | 75 ± 14 | − 37 ± 4 | 123 ± 10 | |
Kd2b (nM) | – | 93 ± 40 | – | 82 ± 42 | |
ΔH2 (kJ/mol) | – | − 4.4 ± 4.4 | – | − 12.8 ± 0.6 | |
ΔS2 (J/mol/K) | – | 118 ± 19 | – | 93 ± 5 | |
In vitro inhibition of hCK2α | |||||
IC50(μM) | 1.19 ± 0.53 | 0.49 ± 0.33 | 0.78 ± 0.29 | 0.23 ± 0.15 | |
Cell line | Cell viability data, IC50(μM) | ||||
A-431 | 12 ± 2 | 7.8 ± 1.2 | 5.3 ± 0.7 | 2.2 ± 0.3 | 2.02 ± 0.06 |
HEPG2 | 18 ± 4 | 13 ± 2 | 3.3 ± 0.4 | 1.5 ± 0.3 | 2.43 ± 0.14 |
HCT116 | 19 ± 6 | 23 ± 9 | 6.1 ± 1.3 | 1.8 ± 0.3 | 4.7 ± 0.6 |
HCT116p53-/- | 13 ± 3 | 48 ± 18 | 9.4 ± 1.4 | 2.5 ± 0.2 | 2.94 ± 0.13 |